142 related articles for article (PubMed ID: 27994513)
1. LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42.
Ye S; Fujiwara T; Zhou J; Varughese KI; Zhao H
Int J Biol Sci; 2016; 12(12):1488-1499. PubMed ID: 27994513
[TBL] [Abstract][Full Text] [Related]
2. The Cytoplasmic Dynein Associated Protein NDE1 Regulates Osteoclastogenesis by Modulating M-CSF and RANKL Signaling Pathways.
Das BK; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
Cells; 2021 Dec; 11(1):. PubMed ID: 35011575
[TBL] [Abstract][Full Text] [Related]
3. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1.
Ye S; Fowler TW; Pavlos NJ; Ng PY; Liang K; Feng Y; Zheng M; Kurten R; Manolagas SC; Zhao H
PLoS One; 2011; 6(11):e27285. PubMed ID: 22073305
[TBL] [Abstract][Full Text] [Related]
4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
5. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
6. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
7. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
8. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
[TBL] [Abstract][Full Text] [Related]
9. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.
De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V
J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140
[TBL] [Abstract][Full Text] [Related]
10. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
11. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
13. Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways.
Guo S; Ni Y; Ben J; Xia Y; Zhou T; Wang D; Ni J; Bai H; Wang L; Ma J; Chen Q
Int J Biol Sci; 2016; 12(10):1155-1167. PubMed ID: 27766031
[TBL] [Abstract][Full Text] [Related]
14. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.
Lamothe B; Lai Y; Xie M; Schneider MD; Darnay BG
Mol Cell Biol; 2013 Feb; 33(3):582-95. PubMed ID: 23166301
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.
Duplomb L; Baud'huin M; Charrier C; Berreur M; Trichet V; Blanchard F; Heymann D
Endocrinology; 2008 Jul; 149(7):3688-97. PubMed ID: 18403479
[TBL] [Abstract][Full Text] [Related]
16. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
[TBL] [Abstract][Full Text] [Related]
17. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.
Luo J; Yang Z; Ma Y; Yue Z; Lin H; Qu G; Huang J; Dai W; Li C; Zheng C; Xu L; Chen H; Wang J; Li D; Siwko S; Penninger JM; Ning G; Xiao J; Liu M
Nat Med; 2016 May; 22(5):539-46. PubMed ID: 27064449
[TBL] [Abstract][Full Text] [Related]
18. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.
Strålberg F; Henning P; Gjertsson I; Kindlund B; Souza PP; Persson E; Abrahamson M; Kasprzykowski F; Grubb A; Lerner UH
FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis.
Yamaguchi T; Movila A; Kataoka S; Wisitrasameewong W; Ruiz Torruella M; Murakoshi M; Murakami S; Kawai T
Infect Immun; 2016 Oct; 84(10):2802-12. PubMed ID: 27456834
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled RANK induces osteoclastogenesis ligand-independently.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
